(7Z,10Z,13Z,16Z,19Z)-Docosapentaenoic acid (BioCAD00000000683)

blood feces urine placenta

Metabolite Card

Formula: C22H34O2 (330.2559)
SMILES: CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O

Synonyms [en]

clupanodonic acid; 7Z,10Z,13Z,16Z,19Z-Docosapentaenoic acid; (7Z,10Z,13Z,16Z,19Z)-Docosa-7,10,13,16,19-pentaenoic acid; (7Z,10Z,13Z,16Z,19Z)-Docosapentaenoic acid; docosapentaenoic acid; cis-7,10,13,16,19-docosapentaenoic acid

Reviewed

Last reviewed on 2024-06-28.

Cite this Page

(7Z,10Z,13Z,16Z,19Z)-Docosapentaenoic acid. 数据之源,洞见之始. SMRUCC genomics institute, a synthetic life researcher from China. https://biocad_registry.innovation.ac.cn/s/(-)-arctiin (retrieved 2026-01-03) (CAD Registry RN: BioCAD00000000683). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

Note

Docosapentaenoic acid (22n-3) (also known as clupanodonic acid) is an essential omega-3 fatty acid (EFA) which is prevalent in fish oils. Docosapentaenoic acid, commonly called DPA, is an intermediary between eicosapentaenoic acid (EPA, 20:5 ω-3) and docosahexaenoic acid (DHA, 22:6 ω-3). Seal oil is a rich source of this metabolite. There are three functions of docosapentaenoic acid. Most importantly, it is a component of phospholipids found in all animal cell membranes, and a deficiency of docosapentaenoic acid leads to faulty membranes being formed. Secondly, it is involved in the transport and oxidation of cholesterol, and clupanodonic acid tends to lower plasma cholesterol. A third function is as a precursor of prostanoids which are only formed from docosapentaenoic acid. Deficiency of this in experimental animals causes lesions mainly attributable to faulty cellular membranes. Outcomes include sudden failure of growth, lesions of the skin, kidney, and connective tissue, erythrocyte fragility, impaired fertility, and the uncoupling of oxidation and phosphorylation. In humans, pure deficiency of docosapentaenoic acid has been studied particularly in persons fed intravenously. A relative deficiency (that is, a low ratio in the body of docosapentaenoic to long-chain saturated fatty acids and isomers of docosapentaenoate) is common in Western diets and plays an important part in the causation of atherosclerosis, coronary thrombosis, multiple sclerosis, the triopathy of diabetes mellitus, hypertension, and certain forms of malignant disease. Various factors affect the dietary requirement of docosapentaenoic acid (PMID: 6469703).

Entity Information

DBLinks

Other DBLinks
  • CAS Registry Number: 24880-45-3
  • CAS Registry Number: 2548-85-8
  • PubChem: 5497182
  • ChEBI: ChEBI:53488
  • HMDB: HMDB0006528
  • HMDB: HMDB01976
  • HMDB: HMDB06528
  • LipidMaps: LMFA04000044
  • KEGG: C16513
  • BioCyc: CPD-13792
  • NCBI MeSH: docosapentaenoic acid
  • Wikipedia: Docosapentaenoic acid
  • RefMet: RM0153164
  • MoNA: LipidBlast2022_953905
  • MoNA: LipidBlast417823
  • MoNA: MT000020
  • Metlin: METLIN_194
  • Metlin: METLIN_24096

Class / Ontology

Metabolic Network
ID EC Number Name
KEGG:R08189 3.1.2.- C16166 + C00001<=>C00010 + C16513
BioCyc:RXN-13446 3.1.2.- CPD-14426 + WATER --> CPD-13792 + CO-A + PROTON
BioCyc:RXN-13011 3.1.2.14 DOCOSAPENTAENOYL-ACP + WATER --> CPD-13792 + ACP + PROTON
View More
Organism Source

Taxonomy Source

Pathway Synthetic

pathway id name
WikiPathways:WP4350 Omega-3 / omega-6 fatty acid synthesis
WikiPathways:WP4491 Elongation of (very) long chain fatty acids
WikiPathways:WP4723 Omega-3 / omega-6 fatty acid synthesis
PathBank:SMP0087429 Alpha Linolenic Acid and Linoleic Acid Metabolism
PathBank:SMP0000018 Alpha Linolenic Acid and Linoleic Acid Metabolism
PathBank:SMP0087171 Alpha Linolenic Acid and Linoleic Acid Metabolism
PathBank:SMP0087372 Alpha Linolenic Acid and Linoleic Acid Metabolism
PathBank:SMP0087279 Alpha Linolenic Acid and Linoleic Acid Metabolism
PathBank:SMP0063593 Alpha Linolenic Acid and Linoleic Acid Metabolism
View All Pathways